Derek Maetzold, president and CEO of Castle Biosciences, see...
Derek Maetzold, president and CEO of Castle Biosciences, sees the robust revenue and test volume growth as a testament to their successful execution of growth initiatives. He is optimistic about the sustainability of this growth and momentum into 2024.
Press Release: Castle Biosciences Announces Preliminary Fourth Quarter and Full-Year 2023 Results
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
3164Followers
0Following
7916Visitors
Follow